DIFFERENTIATION DEPENDENT EXPRESSION OF P-GLYCOPROTEIN IN THE NORMAL AND NEOPLASTIC HUMAN KIDNEY

被引:52
作者
VANKALKEN, CK
VANDERVALK, P
HADISAPUTRO, MMN
PIETERS, R
BROXTERMAN, HJ
KUIPER, CM
SCHEFFER, GL
VEERMAN, AJP
MEYER, CJLM
SCHEPER, RJ
PINEDO, HM
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,1007 MB AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT PEDIAT,1007 MB AMSTERDAM,NETHERLANDS
关键词
P-GLYCOPROTEIN; IMMUNOHISTOCHEMISTRY; DIFFERENTIATION; RENAL CELL CANCER; NEPHROBLASTOMA; FETAL KIDNEY;
D O I
10.1093/oxfordjournals.annonc.a057825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adult renal cell carcinoma (RCC) is clinically resistant to chemotherapy. However, in nephroblastoma (NBL) chemotherapy has increased survival dramatically. We studied the P-glycoprotein (P-gp) expression of 18 RCC and 9 NBL as well as 1 benign renal adenoma and fetal renal tissue using three different monoclonal antibodies (MRK-16, C-219, JSB-1). P-gp was found positive with all three antibodies in 12/18 RCC, while only 2 tumors were completely negative. Staining varied with respect to intensity and number of positive cells [5%-90%]. Intense staining was seen at the apical side of malignant tubules in well differentiated parts of RCC and in tubular structures of the benign renal adenoma. Poorly differentiated parts of the tumors showed less staining. In NBL blastemal parts were negative. In 4/8 specimens showing focal epithelial differentiation, however, the luminal side of more differentiated tubular structures did stain, strongly resembling P-gp staining in the developing fetal human kidney. These results indicate that P-gp expression in normal (fetal) human kidney as well as in benign and malignant tumors derived from this organ depends on the degree of differentiation of tubules, which may have implications for chemotherapy sensitivity in both malignant tumors.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 32 条
[1]   ANAPLASTIC WILMS TUMOR - CLINICAL AND PATHOLOGIC-STUDIES [J].
BONADIO, JF ;
STORER, B ;
NORKOOL, P ;
FAREWELL, VT ;
BECKWITH, JB ;
DANGIO, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :513-520
[2]  
BROXTERMAN H J, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P527
[3]   DAUNOMYCIN ACCUMULATION IN RESISTANT TUMOR-CELLS AS A SCREENING MODEL FOR RESISTANCE MODIFYING DRUGS - ROLE OF PROTEIN-BINDING [J].
BROXTERMAN, HJ ;
KUIPER, CM ;
SCHUURHUIS, GJ ;
VANDERHOEVEN, JJM ;
PINEDO, HM ;
LANKELMA, J .
CANCER LETTERS, 1987, 35 (01) :87-95
[4]   IMMUNOHISTOCHEMICAL DETECTION OF P-GLYCOPROTEIN IN HUMAN-TUMOR CELLS WITH A LOW DEGREE OF DRUG-RESISTANCE [J].
BROXTERMAN, HJ ;
PINEDO, HM ;
KUIPER, CM ;
VANDERHOEVEN, JJM ;
DELANGE, P ;
QUAK, JJ ;
SCHEPER, RJ ;
KEIZER, HG ;
SCHUURHUIS, GJ ;
LANKELMA, J .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (02) :340-343
[5]  
CHAN HSL, 1988, LAB INVEST, V59, P870
[6]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[7]  
DALTON WS, 1989, BLOOD, V73, P747
[8]  
DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO
[9]  
2-Q
[10]  
FOJO A, 1985, CANCER RES, V45, P3002